Price (delayed)
$6.11
Market cap
$902.46M
P/E Ratio
22.63
Dividend/share
N/A
EPS
$0.27
Enterprise value
$814.69M
MiMedx is an industry leader in utilizing birth tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare.
There are no recent dividends present for MDXG.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.